KBI BIOPHARMA Trademark

Trademark Overview

On Monday, March 12, 2012, a trademark application was filed for KBI BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the KBI BIOPHARMA trademark a serial number of 85566501. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, December 16, 2022. This trademark is owned by KBI Biopharma, Inc.. The KBI BIOPHARMA trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

contract manufacturing in the field of biopharmaceuticals

contract biopharmaceutical drug development services
kbi biopharma

General Information

Serial Number85566501
Word MarkKBI BIOPHARMA
Filing DateMonday, March 12, 2012
Status800 - REGISTERED AND RENEWED
Status DateFriday, December 16, 2022
Registration Number4340914
Registration DateTuesday, May 28, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2013

Trademark Statements

Goods and Servicescontract manufacturing in the field of biopharmaceuticals
Pseudo MarkKBI BIOPHARMACEUTICAL
Disclaimer with Predetermined Text"BIOPHARMA"
Goods and Servicescontract biopharmaceutical drug development services

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, January 31, 2013
Primary Code040
First Use Anywhere DateMonday, December 31, 2001
First Use In Commerce DateMonday, December 31, 2001
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 19, 2012
Primary Code042
First Use Anywhere DateMonday, December 31, 2001
First Use In Commerce DateMonday, December 31, 2001

Trademark Owner History

Party NameKBI Biopharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27704
Party NameKBI Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27704
Party NameKBI Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27704

Trademark Events

Event DateEvent Description
Friday, December 16, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, December 16, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, December 16, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, December 15, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 1, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, May 28, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, July 6, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, July 6, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, July 6, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 28, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, May 28, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 23, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 28, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, March 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 5, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 31, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 31, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 31, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 31, 2013ASSIGNED TO LIE
Wednesday, January 30, 2013NOTICE OF REVIVAL - E-MAILED
Tuesday, January 29, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 29, 2013PETITION TO REVIVE-GRANTED
Tuesday, January 29, 2013TEAS PETITION TO REVIVE RECEIVED
Tuesday, January 29, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 22, 2013ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 22, 2013ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 26, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 26, 2012NON-FINAL ACTION E-MAILED
Tuesday, June 26, 2012NON-FINAL ACTION WRITTEN
Tuesday, June 19, 2012ASSIGNED TO EXAMINER
Tuesday, March 20, 2012NOTICE OF PSEUDO MARK MAILED
Monday, March 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 15, 2012NEW APPLICATION ENTERED

Related Keywords

biopharma contract development services drug biopharmaceuticals manufacturing field biopharmaceutical